InvestSMART

Island Pharmaceuticals Limited (ASX: ILA) - Announcements

Current share price for ILA : $0.470 0.01 (2.08%)+

ASX company news and announcements for Island Pharmaceuticals Limited (ILA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Island Pharmaceuticals Limited (ILA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Island Pharmaceuticals Limited (ILA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Island Pharmaceuticals Limited (ILA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$139 Cleansing Notice 9 Sep 2025 8:29AM $0.300 $0.470 risen by 56.67%
$139 Application for quotation of securities - ILA 9 Sep 2025 8:29AM $0.300 $0.470 risen by 56.67%
$139 Letter to Shareholders, Notice of AGM & Proxy Form 5 Sep 2025 9:44AM $0.270 $0.470 risen by 74.07%
$139 FDA meeting request lodged for Galidesivir 1 Sep 2025 8:45AM $0.220 $0.470 risen by 113.64%
$139 FDA meeting request lodged for Galidesivir 1 Sep 2025 8:45AM $0.220 $0.470 risen by 113.64%
$139 Annual Report to shareholders (incl auditor independence) 29 Aug 2025 10:09AM $0.215 $0.470 risen by 118.60%
$139 Appendix 4G and Corporate Governance Statement 29 Aug 2025 8:27AM $0.215 $0.470 risen by 118.60%
$139 Annual Report to shareholders 29 Aug 2025 8:25AM $0.215 $0.470 risen by 118.60%
$139 Preliminary Final Report 29 Aug 2025 8:22AM $0.215 $0.470 risen by 118.60%
$139 Preliminary Final Report 29 Aug 2025 8:22AM $0.215 $0.470 risen by 118.60%
$139 Change in substantial holding 15 Aug 2025 10:07AM $0.185 $0.470 risen by 154.05%
$139 Date of AGM & Closing Date for Director Nominations 14 Aug 2025 12:08PM $0.180 $0.470 risen by 161.11%
$139 Presentation to the Third Annual Dengue Endgame Summit 14 Aug 2025 9:32AM $0.195 $0.470 risen by 141.03%
$139 Options exercise from existing substantial shareholder 11 Aug 2025 9:55AM $0.210 $0.470 risen by 123.81%
$139 Cleansing Notice 11 Aug 2025 9:52AM $0.210 $0.470 risen by 123.81%
$139 Application for quotation of securities - ILA 11 Aug 2025 9:51AM $0.210 $0.470 risen by 123.81%
$139 Completion of Galidesivir transaction 31 Jul 2025 8:22AM $0.170 $0.470 risen by 176.47%
$139 Investor Presentation and investor roadshow 28 Jul 2025 1:22PM $0.160 $0.470 risen by 193.75%
$139 Change of Director's Interest Notice - JC 25 Jul 2025 8:36AM $0.170 $0.470 risen by 176.47%
$139 Quarterly Appendix 4C and Activities Report 24 Jul 2025 9:00AM $0.150 $0.470 risen by 213.33%
$139 Change in substantial holding 17 Jul 2025 10:33AM $0.165 $0.470 risen by 184.85%
$139 Options exercise from existing substantial shareholder 17 Jul 2025 10:32AM $0.165 $0.470 risen by 184.85%
$139 Cleansing Notice 16 Jul 2025 8:29AM $0.145 $0.470 risen by 224.14%
$139 Application for quotation of securities - ILA 16 Jul 2025 8:23AM $0.145 $0.470 risen by 224.14%
$139 Investor presentation 9 Jul 2025 9:22AM $0.145 $0.470 risen by 224.14%

76 - 100 of 441 results

Page 4 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.